Progenics Pharma (PGNX) Presented AZEDRA (iobenguane I 131) Biochemical Tumor Marker Data at ENDO 2018

March 19, 2018 8:32 AM

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) announced that biochemical tumor marker data from the Company’s pivotal Phase 2 trial of its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found